NEW YORK, May 23, 2017 /PRNewswire-USNewswire/ -- Northwell Health today announced a new partnership agreement with
The move further solidifies Northwell's commitment to improving the patient experience and the health of the communities it serves throughout the New York metropolitan area, and reducing operational cost.
"Our collaboration with Peerbridge Health is part of our overarching strategy to introduce disruptive technologies that will help shape the future of health care delivery," said Michael Dowling, president and CEO of Northwell Health.
To better understand the potential of this partnership, Peerbridge Health and Northwell conducted a clinical trial to measure the performance of the company's flagship product, the Peerbridge Cor™, a compact, lightweight, multi-channel electrocardiogram monitor. To ensure efficacy, the Peerbridge Cor was compared to other cardiovascular monitors in a clinical trial. "The trial demonstrated this technology was superior to the current Holter Monitor standard," said Nicholas Skipitaris, MD, chief of electrophysiology at Lenox Hill Hospital. "Not only did the Peerbridge Cor deliver excellent, multi-channel, analyzable data, but it delivered less motion artifact and fewer false positives, despite our patient's active New York lifestyle."
"Our vision is to help consumers partner with their physicians through easily accessible remote monitoring options," said Arthur Bertolero, CEO of Peerbridge Health. "Northwell has been a strong strategic partner, sharing our passion to bring effective digital solutions to consumers and health professionals with the highest medical standard."
Incidence/Cost of CardiovascularThe American Heart Association reports cardiovascular disease and stroke as the top two killers of American adults. Cardiovascular monitoring, both inside and outside medical environments, is critical for diagnosis, proper treatment, and improved outcomes.
According to the US Center for Disease Control & Prevention Foundation, annual direct medical costs associated with cardiovascular diseases are projected to rise to more than $818 billion by 2030. To get ahead of the growth in patient demand, an increasing number of providers are looking for more efficient monitoring like Peerbridge to improve treatment and deliver better outcomes, which also has the potential to significantly reduce expenses.
About Northwell HealthNorthwell Health is New York State's largest health care provider and private employer, with 22 hospitals and over 550 outpatient facilities. We care for more than two million people annually in the metro New York area and beyond, thanks to philanthropic support from our communities. Our 61,000 employees – 15,000+ nurses and nearly 3,900 physicians, including about 2,800 members of Northwell Health Physician Partners -- are working to change health care for the better. We're making breakthroughs in medicine at the Feinstein Institute. We're training the next generation of medical professionals at the visionary Hofstra Northwell School of Medicine and the School of Graduate Nursing and Physician Assistant Studies. And we offer health insurance through CareConnect. For information on our more than 100 medical specialties, visit Northwell.edu.
About Peerbridge HealthHeadquartered in New York, NY, Peerbridge Health, Inc. (PBH) is a venture capital backed Health IT and wearable technology company. PBH seeks to improve remote monitoring through thoughtful design and a seamless user experience. The company's current focus is to bring a new freedom and precision to remote cardiac monitoring with its initial product release scheduled for 2017. The company has two digital health and fitness pioneering patents for medical grade monitoring of all vital signs; 7,979,111 and 9,101,264, with other patents pending.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/northwell-health-makes-strategic-move-into-wearable-technology-300462368.html
SOURCE Northwell Health
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All